PubMed registered articles

Zhenhe Suo

Publications published since 1991 or in press by Zhenhe Suo

53 publications found

Publications in press

  1. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Giercksky KE, Nesland JM, Suo Z
    Synergistic effect of SCF and G-CSF on stem-like properties in prostate cancer cell lines
    Tumour Biol (in press)
    PubMed 22252524

Publications 2011

  1. Bruheim S, Kristian A, Uenaka T, Suo Z, Tsuruoka A, Nesland JM, Fodstad Ø (2011)
    Antitumour activity of oral E7080, a novel inhibitor of multiple tyrosine kinases, in human sarcoma xenografts
    Int J Cancer, 129 (3), 742-50
    PubMed 21225632
  2. Han LP, Liu JF, Liu XR, Dong ZM, Suo ZH (2011)
    [Expression and prognostic significance of EphA2 and EphrinA-1 in ovarian serous carcinomas]
    Sichuan Da Xue Xue Bao Yi Xue Ban, 42 (2), 179-84
    PubMed 21500549
  3. Lü X, Xu K, Lü H, Yin Y, Ma C, Liu Y, Li H, Suo Z (2011)
    CD44(+)/CD24(-) cells are transit progenitors and do not determine the molecular subtypes and clinical parameters in breast carcinomas
    Ultrastruct Pathol, 35 (2), 72-8
    PubMed 21299347
  4. Ma Y, Liang D, Liu J, Axcrona K, Kvalheim G, Stokke T, Nesland JM, Suo Z (2011)
    Prostate cancer cell lines under hypoxia exhibit greater stem-like properties
    PLoS One, 6 (12), e29170
    PubMed 22216200
  5. Shi JH, Huitfeldt HS, Suo ZH, Line PD (2011)
    Growth of hepatocellular carcinoma in the regenerating liver
    Liver Transpl, 17 (7), 866-74
    PubMed 21542129
  6. Wang Z, Nesland JM, Suo Z, Trope CG, Holm R (2011)
    The prognostic value of 14-3-3 isoforms in vulvar squamous cell carcinoma cases: 14-3-3? and ? are independent prognostic factors for these tumors
    PLoS One, 6 (9), e24843
    PubMed 21935479

Publications 2010

  1. Chen X, Cao X, Dong W, Luo S, Suo Z, Jin Y (2010)
    Expression of TIP30 tumor suppressor gene is down-regulated in human colorectal carcinoma
    Dig Dis Sci, 55 (8), 2219-26
    PubMed 19798571
  2. Prasmickaite L, Engesaeter BØ, Skrbo N, Hellenes T, Kristian A, Oliver NK, Suo Z, Maelandsmo GM (2010)
    Aldehyde dehydrogenase (ALDH) activity does not select for cells with enhanced aggressive properties in malignant melanoma
    PLoS One, 5 (5), e10731
    PubMed 20505780
  3. Prasmickaite L, Skrbo N, Høifødt HK, Suo Z, Engebråten O, Gullestad HP, Aamdal S, Fodstad Ø, Maelandsmo GM (2010)
    Human malignant melanoma harbours a large fraction of highly clonogenic cells that do not express markers associated with cancer stem cells
    Pigment Cell Melanoma Res, 23 (3), 449-51
    PubMed 20236249
  4. Wang Z, He W, Yang G, Wang J, Wang Z, Nesland JM, Holm R, Suo Z (2010)
    Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma
    BMC Cancer, 10, 352
    PubMed 20602752
  5. Wang Z, Trope CG, Flørenes VA, Suo Z, Nesland JM, Holm R (2010)
    Overexpression of CDC25B, CDC25C and phospho-CDC25C (Ser216) in vulvar squamous cell carcinomas are associated with malignant features and aggressive cancer phenotypes
    BMC Cancer, 10, 233
    PubMed 20500813

Publications 2009

  1. Fan T, Jiang G, Suo Z, Liu H, Xu P, Ji Z, Zhang L, Yang G (2009)
    Down-regulation of the apoptosis-inducing factor or Bcl-2 inhibitor of transcription by RNA interference can alleviate TAp63gamma-induced apoptosis in esophageal squamous carcinoma EC9706 cells
    Int J Oncol, 35 (2), 359-67
    PubMed 19578750
  2. Gao Q, Geng L, Kvalheim G, Gaudernack G, Suo Z (2009)
    Identification of cancer stem-like side population cells in ovarian cancer cell line OVCAR-3
    Ultrastruct Pathol, 33 (4), 175-81
    PubMed 19728235
  3. Goscinski MA, Larsen SG, Warloe T, Stoldt S, Nesland JM, Suo ZH, Giercksky KE (2009)
    Adenocarcinomas on the rise--does it influence survival from oesophageal cancer?
    Scand J Surg, 98 (4), 214-20
    PubMed 20218417
  4. He W, Wang Z, Wang Q, Fan Q, Shou C, Wang J, Giercksky KE, Nesland JM, Suo Z (2009)
    Expression of HIWI in human esophageal squamous cell carcinoma is significantly associated with poorer prognosis
    BMC Cancer, 9, 426
    PubMed 19995427
  5. Liu Y, Geng L, Suo Z (2009)
    Differentiation effect of pyruvate and uridine on cultured U937-rho degrees cells
    Ultrastruct Pathol, 33 (4), 160-4
    PubMed 19728232
  6. Lü X, Li H, Xu K, Nesland JM, Suo Z (2009)
    MUC-1-/ESA+ progenitor cells in normal, benign and malignant human breast epithelial cells
    Histol Histopathol, 24 (11), 1381-90
    PubMed 19760587
  7. Lü XQ, Suo Z, Ma CL, Xu KJ, Liu YS, Li HX (2009)
    [Quantity and distribution of CD44+/CD24- cells in breast cancer tissue and the cell lines]
    Zhonghua Bing Li Xue Za Zhi, 38 (7), 441-4
    PubMed 19781189
  8. Wang Q, He W, Lu C, Wang Z, Wang J, Giercksky KE, Nesland JM, Suo Z (2009)
    Oct3/4 and Sox2 are significantly associated with an unfavorable clinical outcome in human esophageal squamous cell carcinoma
    Anticancer Res, 29 (4), 1233-41
    PubMed 19414369

Publications 2008

  1. Goscinski MA, Suo Z, Flørenes VA, Vlatkovic L, Nesland JM, Giercksky KE (2008)
    FAP-alpha and uPA show different expression patterns in premalignant and malignant esophageal lesions
    Ultrastruct Pathol, 32 (3), 89-96
    PubMed 18570153
  2. Goscinski MA, Suo ZH, Nesland JM, Chen WT, Zakrzewska M, Wang J, Zhang S, Flørenes VA, Giercksky KE (2008)
    Seprase, dipeptidyl peptidase IV and urokinase-type plasminogen activator expression in dysplasia and invasive squamous cell carcinoma of the esophagus. A study of 229 cases from Anyang Tumor Hospital, Henan Province, China
    Oncology, 75 (1-2), 49-59
    PubMed 18787344
  3. Goscinski MA, Suo ZH, Nesland JM, Flørenes VA, Giercksky KE (2008)
    Dipeptidyl peptidase IV expression in cancer and stromal cells of human esophageal squamous cell carcinomas, adenocarcinomas and squamous cell carcinoma cell lines
    APMIS, 116 (9), 823-31
    PubMed 19024603
  4. Holm R, de Putte GV, Suo Z, Lie AK, Kristensen GB (2008)
    Expressions of EphA2 and EphrinA-1 in early squamous cell cervical carcinomas and their relation to prognosis
    Int J Med Sci, 5 (3), 121-6
    PubMed 18566674
  5. Wang Z, Tropè CG, Suo Z, Trøen G, Yang G, Nesland JM, Holm R (2008)
    The clinicopathological and prognostic impact of 14-3-3 sigma expression on vulvar squamous cell carcinomas
    BMC Cancer, 8, 308
    PubMed 18950492
  6. Zhang MZ, Qiao YH, Suo ZH (2008)
    [Correlation of DPPIV expression with clinicopathological features and prognosis in epithelial ovarian carcinoma]
    Zhonghua Zhong Liu Za Zhi, 30 (11), 848-52
    PubMed 19173831

Publications 2007

  1. Wang Q, Wang T, Wang Y, Wang W, Wang Y, Hu X, Shao S, Zhang J, Suo Z (2007)
    VP-16 resistance in the NCI-H460 human lung cancer cell line is significantly associated with glucose-regulated protein78 (GRP78) induction
    Anticancer Res, 27 (4B), 2359-64
    PubMed 17695526
  2. Wu Q, Lind GE, Aasheim HC, Micci F, Silins I, Tropé CG, Nesland JM, Lothe RA, Suo Z (2007)
    The EPH receptor Bs (EPHBs) promoters are unmethylated in colon and ovarian cancers
    Epigenetics, 2 (4), 237-43
    PubMed 18281782
  3. Wu Q, Lothe RA, Ahlquist T, Silins I, Tropé CG, Micci F, Nesland JM, Suo Z, Lind GE (2007)
    DNA methylation profiling of ovarian carcinomas and their in vitro models identifies HOXA9, HOXB5, SCGB3A1, and CRABP1 as novel targets
    Mol Cancer, 6, 45
    PubMed 17623056
  4. Zhang MZ, Qiao YH, Nesland JM, Trope C, Kennedy A, Chen WT, Suo ZH (2007)
    Expression of seprase in effusions from patients with epithelial ovarian carcinoma
    Chin Med J (Engl), 120 (8), 663-8
    PubMed 17517181

Publications 2006

  1. Aghmesheh M, Suo Z, Friedlander M, Nesland JM, Kaern J, Stewart M, Kconfab, Dorum A, Tucker KM, Buckley MF (2006)
    Chromosome 2q24.2 is lost in sporadic but not in BRCA1-associated ovarian carcinomas
    Pathology, 38 (2), 145-51
    PubMed 16680901
  2. Chen D, Kennedy A, Wang JY, Zeng W, Zhao Q, Pearl M, Zhang M, Suo Z, Nesland JM, Qiao Y, Ng AK, Hirashima N, Yamane T, Mori Y, Mitsumata M, Ghersi G, Chen WT (2006)
    Activation of EDTA-resistant gelatinases in malignant human tumors
    Cancer Res, 66 (20), 9977-85
    PubMed 17047060
  3. Han LP, Dong ZM, Qiao YH, Nesland JM, Suo ZH (2006)
    [Expressions of estrogen receptor subtypes in epithelial ovarian carcinomas]
    Sichuan Da Xue Xue Bao Yi Xue Ban, 37 (4), 606-10
    PubMed 16909613
  4. Ji Z, Yang G, Shahzidi S, Tkacz-Stachowska K, Suo Z, Nesland JM, Peng Q (2006)
    Induction of hypoxia-inducible factor-1alpha overexpression by cobalt chloride enhances cellular resistance to photodynamic therapy
    Cancer Lett, 244 (2), 182-9
    PubMed 16427735
  5. Ji Z, Yang G, Vasovic V, Cunderlikova B, Suo Z, Nesland JM, Peng Q (2006)
    Subcellular localization pattern of protoporphyrin IX is an important determinant for its photodynamic efficiency of human carcinoma and normal cell lines
    J Photochem Photobiol B, 84 (3), 213-20
    PubMed 16709459
  6. Wu Q, Suo Z, Kristensen GB, Baekelandt M, Nesland JM (2006)
    The prognostic impact of EphB2/B4 expression on patients with advanced ovarian carcinoma
    Gynecol Oncol, 102 (1), 15-21
    PubMed 16499955

Publications 2005

  1. Han L, Dong Z, Qiao Y, Kristensen GB, Holm R, Nesland JM, Suo Z (2005)
    The clinical significance of EphA2 and Ephrin A-1 in epithelial ovarian carcinomas
    Gynecol Oncol, 99 (2), 278-86
    PubMed 16061279
  2. Shi HR, Wu QH, Suo ZH, Nesland JM (2005)
    [Correlation between methylation of 5'-CpG islands and inactivation of FHIT gene in cervical cancer]
    Ai Zheng, 24 (1), 7-11
    PubMed 15642192
  3. Xu F, Zhong W, Li J, Shanshen Z, Cui J, Nesland JM, Suo Z (2005)
    Predictive value of EphA2 and EphrinA-1 expression in oesophageal squamous cell carcinoma
    Anticancer Res, 25 (4), 2943-50
    PubMed 16080548

Publications 2004

  1. Davidson B, Suo Z, Nesland JM (2004)
    Malignant mesothelioma
    Ultrastruct Pathol, 28 (4), 179-80
    PubMed 15693629
  2. Suo Z, Daehli KU, Lindboe CF, Borgen E, Bassarova A, Nesland JM (2004)
    Real-time PCR quantification of c-erbB-2 gene is an alternative for FISH in the clinical management of breast carcinoma patients
    Int J Surg Pathol, 12 (4), 311-8
    PubMed 15494857
  3. Suo Z, Karbovo E, Trope CG, Metodiev K, Nesland JM (2004)
    Papillary serous carcinoma of the ovary: an ultrastructural and immunohistochemical study
    Ultrastruct Pathol, 28 (3), 141-7
    PubMed 15471427
  4. Wu D, Qiao Y, Kristensen GB, Li S, Troen G, Holm R, Nesland JM, Suo Z (2004)
    Prognostic significance of dysadherin expression in cervical squamous cell carcinoma
    Pathol Oncol Res, 10 (4), 212-8
    PubMed 15619642
  5. Wu D, Suo Z, Kristensen GB, Li S, Troen G, Holm R, Nesland JM (2004)
    Prognostic value of EphA2 and EphrinA-1 in squamous cell cervical carcinoma
    Gynecol Oncol, 94 (2), 312-9
    PubMed 15297167
  6. Wu Q, Suo Z, Risberg B, Karlsson MG, Villman K, Nesland JM (2004)
    Expression of Ephb2 and Ephb4 in breast carcinoma
    Pathol Oncol Res, 10 (1), 26-33
    PubMed 15029258

Publications 2003

  1. Suo Z, Nesland JM (2003)
    Electron microscopy in diagnosis of spindle cell tumors
    Semin Diagn Pathol, 20 (1), 5-12
    PubMed 12693671
  2. Wu Q, Shi H, Suo Z, Nesland JM (2003)
    5'-CpG island methylation of the FHIT gene is associated with reduced protein expression and higher clinical stage in cervical carcinomas
    Ultrastruct Pathol, 27 (6), 417-22
    PubMed 14660280

Publications 2002

  1. Suo Z, Nesland JM (2002)
    Barrett's esophagus: intestinal metaplasia or phenotypic shift of undifferentiated elements in the stem cells
    Ultrastruct Pathol, 26 (2), 53-4
    PubMed 12036092
  2. Suo Z, Nesland JM (2002)
    Type 1 protein tyrosine kinases in breast carcinoma: a review
    Ultrastruct Pathol, 26 (3), 125-35
    PubMed 12184370
  3. Suo Z, Risberg B, Kalsson MG, Willman K, Tierens A, Skovlund E, Nesland JM (2002)
    EGFR family expression in breast carcinomas. c-erbB-2 and c-erbB-4 receptors have different effects on survival
    J Pathol, 196 (1), 17-25
    PubMed 11748637
  4. Suo Z, Risberg B, Karlsson MG, Villman K, Skovlund E, Nesland JM (2002)
    The expression of EGFR family ligands in breast carcinomas
    Int J Surg Pathol, 10 (2), 91-9
    PubMed 12075402
  5. Yang H, Berner A, Mei Q, Giercksky KE, Warloe T, Yang G, Cui J, Suo Z, Zhang S, Nesland JM (2002)
    Cytologic screening for esophageal cancer in a high-risk population in Anyang County, China
    Acta Cytol, 46 (3), 445-52
    PubMed 12040635

Publications 1991

  1. Suo ZH, Hu ZL (1991)
    Case for the panel. Cytoplasmic structures in the cells of esophageal squamous cell carcinomas
    Ultrastruct Pathol, 15 (3), 309-10
    PubMed 1871903